@article{ef91c24acc2e4731ba08b40c1e980fa9,
title = "Isolation of time-dependent DNA damage induced by energetic carbon ions and their fragments using fluorescent nuclear track detectors",
abstract = "Purpose: High energetic carbon (C-) ion beams undergo nuclear interactions with tissue, producing secondary nuclear fragments. Thus, at depth, C-ion beams are composed of a mixture of different particles with different linear energy transfer (LET) values. We developed a technique to enable isolation of DNA damage response (DDR) in mixed radiation fields using beam line microscopy coupled with fluorescence nuclear track detectors (FNTDs). Methods: We imaged live cells on a coverslip made of FNTDs right after C-ion, proton or photon irradiation using an in-house built confocal microscope placed in the beam path. We used the FNTD to link track traversals with DNA damage and separated DNA damage induced by primary particles from fragments. Results: We were able to spatially link physical parameters of radiation tracks to DDR in live cells to investigate spatiotemporal DDR in multi-ion radiation fields in real time, which was previously not possible. We demonstrated that the response of lesions produced by the high-LET primary particles associates most strongly with cell death in a multi-LET radiation field, and that this association is not seen when analyzing radiation induced foci in aggregate without primary/fragment classification. Conclusions: We report a new method that uses confocal microscopy in combination with FNTDs to provide submicrometer spatial-resolution measurements of radiation tracks in live cells. Our method facilitates expansion of the radiation-induced DDR research because it can be used in any particle beam line including particle therapy beam lines. Category: Biological Physics and Response Prediction.",
keywords = "DNA damage response, DNA repair, fluorescent nuclear track detectors, live cell imaging, particle therapy",
author = "McFadden, {Conor H.} and Shirin Rahmanian and Flint, {David B.} and Bright, {Scott J.} and Yoon, {David S.} and O{\textquoteright}Brien, {Daniel J.} and Aroumougame Asaithamby and Amir Abdollahi and Steffen Greilich and Sawakuchi, {Gabriel O.}",
note = "Funding Information: This work was supported in part by the University Cancer Foundation via the Sister Institution Network Fund (G.O.S. and S.G.) and Institutional Research Grant Program (G.O.S.) at the University of Texas MD Anderson Cancer Center; by the Seed Grants in Particle Therapy from the Department of Radiation Oncology at The University of Texas Southwestern Medical Center (G.O.S.); by the Cancer Prevention and Research Institute of Texas grant RP170040 (G.O.S.); and by the Cancer Center Support (Core) Grant CA016672 to MD Anderson. It was also supported in part by the National Center for Tumor Diseases (NCT3.0_2015.21/22 NCT‐PRO and Biodose programs) (A. Abdollahi). The authors thank Claudia Rittm{\"u}ller, Julian Schlegel and Dr. Martin Niklas from the Division of Molecular and Translational Radiation Oncology (NCT/HIT) for help with cell culture, fixation, and experiment/beam‐time planning. The authors also thank Hans‐Peter Wieser from DKFZ for help with determining the dose for the clonogenic assays, Dr. Stefan Brons from HIT for help with logistics and dosimetry for C‐ion irradiations, Dr. Juergen Debus for approving C‐ion beam time at HIT, Dr. Narayan Sahoo at the MD Anderson Proton Therapy Center for proton beam‐time scheduling at the MD Anderson Proton Center, and Christine F. Wogan of the Division of Radiation Oncology at MD Anderson for editing the manuscript. Funding Information: This work was supported in part by the University Cancer Foundation via the Sister Institution Network Fund (G.O.S. and S.G.) and Institutional Research Grant Program (G.O.S.) at the University of Texas MD Anderson Cancer Center; by the Seed Grants in Particle Therapy from the Department of Radiation Oncology at The University of Texas Southwestern Medical Center (G.O.S.); by the Cancer Prevention and Research Institute of Texas grant RP170040 (G.O.S.); and by the Cancer Center Support (Core) Grant CA016672 to MD Anderson. It was also supported in part by the National Center for Tumor Diseases (NCT3.0_2015.21/22 NCT-PRO and Biodose programs) (A. Abdollahi). The authors thank Claudia Rittm{\"u}ller, Julian Schlegel and Dr. Martin Niklas from the Division of Molecular and Translational Radiation Oncology (NCT/HIT) for help with cell culture, fixation, and experiment/beam-time planning. The authors also thank Hans-Peter Wieser from DKFZ for help with determining the dose for the clonogenic assays, Dr. Stefan Brons from HIT for help with logistics and dosimetry for C-ion irradiations, Dr. Juergen Debus for approving C-ion beam time at HIT, Dr. Narayan Sahoo at the MD Anderson Proton Therapy Center for proton beam-time scheduling at the MD Anderson Proton Center, and Christine F. Wogan of the Division of Radiation Oncology at MD Anderson for editing the manuscript. Publisher Copyright: {\textcopyright} 2019 American Association of Physicists in Medicine",
year = "2020",
month = jan,
day = "1",
doi = "10.1002/mp.13897",
language = "English (US)",
volume = "47",
pages = "272--281",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "1",
}